Concord Medical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	964.35	889.85	833.2	889.21	738.99
Revenue Growth (YoY)	8.37%	6.80%	-6.30%	20.33%	-8.73%
Cost of Revenue	830.39	780.23	731.06	780.11	670.5
Gross Profit	133.96	109.62	102.15	109.1	68.49
Selling, General & Admin	61.16	47.79	47.23	45	32.86
Operating Expenses	61.19	48.81	47.41	44.31	31.02
Operating Income	72.78	60.81	54.74	64.78	37.47
Interest Expense	-3.89	-3.55	-3.52	-3.51	-4.79
Interest & Investment Income	5.21	3.99	2.87	0.9	1.03
Currency Exchange Gain (Loss)	-	-	-	0.02	-0.17
Other Non Operating Income (Expenses)	-0.12	1.06	0.03	0.26	-0.08
EBT Excluding Unusual Items	73.96	62.3	54.12	62.45	33.47
Gain (Loss) on Sale of Investments	8.8	-	-	-	-
Gain (Loss) on Sale of Assets	0.07	0.15	0.41	1.69	9.16
Other Unusual Items	-	-	-	0.09	0.17
Pretax Income	82.83	62.45	54.53	64.22	42.79
Income Tax Expense	14.9	12.88	11.78	13.58	8.39
Earnings From Continuing Operations	67.93	49.57	42.74	50.64	34.4
Minority Interest in Earnings	-0.57	-	-	0.02	-
Net Income	67.36	49.57	42.74	50.66	34.4
Net Income to Common	67.36	49.57	42.74	50.66	34.4
Net Income Growth	35.90%	15.97%	-15.62%	47.27%	73.96%
Shares Outstanding (Basic)	33	33	33	33	25
Shares Outstanding (Diluted)	34	33	33	33	25
Shares Change (YoY)	0.12%	0.07%	0.17%	33.03%	0.22%
EPS (Basic)	2.02	1.49	1.28	1.52	1.37
EPS (Diluted)	2.01	1.48	1.28	1.52	1.37
EPS Growth	35.81%	15.63%	-15.77%	10.93%	73.42%
Free Cash Flow	123.42	74.12	25.05	117.1	115.63
Free Cash Flow Per Share	3.68	2.21	0.75	3.51	4.61
Dividend Per Share	1.500	1.100	1.000	1.000	0.500
Dividend Growth	36.36%	10.00%	-	100.00%	25.00%
Gross Margin	13.89%	12.32%	12.26%	12.27%	9.27%
Operating Margin	7.55%	6.83%	6.57%	7.29%	5.07%
Profit Margin	6.98%	5.57%	5.13%	5.70%	4.66%
Free Cash Flow Margin	12.80%	8.33%	3.01%	13.17%	15.65%
EBITDA	128.96	119.78	131.35	138.83	111.84
EBITDA Margin	13.37%	13.46%	15.76%	15.61%	15.13%
D&A For EBITDA	56.18	58.97	76.61	74.05	74.37
EBIT	72.78	60.81	54.74	64.78	37.47
EBIT Margin	7.55%	6.83%	6.57%	7.29%	5.07%
Effective Tax Rate	17.99%	20.62%	21.61%	21.15%	19.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.